(secondQuint)Efficacy and Safety of BP1.

4979 in Smoking Cessation.

 BP1.

4979 is a novel compound with promising efficacy on smoker which have been assessed on phase I studies.

 This is a multicenter,randomized, double blind, placebo controlled, phase IIb trial with parallel group to assess safety and efficacy of BP1.

4979 in smoker.

.

 Efficacy and Safety of BP1.

4979 in Smoking Cessation@highlight

Clinical study which aim is to assess in heavy smokers willing to quit smoking the efficacy and the safety profile of BP1.

4979 for smoking cessation on the total abstinence measured by subject diary and confirmed by exhaled CO (abstinent < 10 ppm).

